SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-099352
Filing Date
2024-08-20
Accepted
2024-08-20 21:14:28
Documents
1
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4454
  Complete submission text file 0000950170-24-099352.txt   5965
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
ROBIN HOWARD W (Reporting) CIK: 0001206869 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 241226998